#brukinsa
I don't understand what any of the acronyms in this medication ad are, but I'll take it over the bullshit of the last few weeks.

Sell me your weird drug, Brukinsa. 🤼
October 8, 2025 at 12:33 AM
Weird drug name of the day:

Brukinsa
September 4, 2025 at 11:16 PM
The @fda.gov has approved a new tablet formulation of Brukinsa® (zanubrutinib), which is expected to replace the current capsule formulation in October 2025. From @medicalprofref.bsky.social.

bit.ly/45xrR3b

#lymphoma #lymsm
Brukinsa Tablets Get FDA Nod for All Approved Indications
The Food and Drug Administration has approved a new tablet formulation of Brukinsa® (zanubrutinib).
bit.ly
June 25, 2025 at 7:19 PM
@maddow.msnbc.com: (2/2) (My video editing skills are not great, so the clip begins with the end of a SERVPRO commercial.) Doctors must hate commercials like this, though maybe the pharmaceutical company producing Brukinsa has already bought the appropriate cancer specialists off! Oh, capitalism!
September 14, 2025 at 5:27 PM
Brukinsa
Abrysvo
Gemtesa
September 23, 2026 at 2:53 AM
“But anyway, after this 5 second ad for Brukinsa, here’s yet another reminder of the eternal good despite the obvious bad”
October 9, 2025 at 4:01 AM
November 19, 2024 at 11:00 AM
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025 BRUKINSA now demonstrates best-in-class sustained efficacy and long-term benefit with a favorable safety profile over more th...

#Business #Wire #News #Releases #PMN #Press #Releases #BW

Origin | Interest | Match
BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025
BRUKINSA now demonstrates best-in-class sustained efficacy and long-term benefit with a favorable safety profile over more than six years of follow-up data in treat…
financialpost.com
November 20, 2025 at 11:42 AM
It's great that Mark has provided discounts on so many drugs, but we still need insurance. My meds are not on his list, and cost $14,000 a month (Brukinsa, 320 mg/day). Thankfully it's mostly paid for between Medicare and Highmark insurance.
July 6, 2026 at 11:35 PM
Albeit I have limited knowledge of Brukinsa, it's not a traditional chemotherapy but rather a target therapy. It still can have very serious side effects. Make sure they are monitoring your white blood cells. Especially neutrophils if you get neutopenia, then you should be on Neupogen (filgrastim).
July 24, 2025 at 9:05 PM
📄 #ONC 10-Q — what changed
MD&A now says: "Key highlights for the second quarter of 2026 are as follows: • Second quarter 2026 total global revenues increased 30% to $1.7 billion versus second quarter 2025 • Global BRUKINSA ® (zanubrutinib) revenues increased 31% to $1.2 billion ve
FormDelta — Insider Trading Alerts
What BeOne Medicines Ltd. changed in their own words, quarter over quarter.
www.formdelta.com
September 10, 2026 at 8:58 PM
📢 Beigene is #hiring a Senior Manager, Marketing – Brukinsa!

🌎 Worldwide
👵 Senior

🔗 http://jbs.ink/rh6xERN4ZzYB

#jobalert #jobsearch #aviationjobs #remotejob #remotework #wfh #aws #marketing
September 6, 2026 at 8:50 PM
BeOne Medicines Pivots R&D, Slashes BRUKINSA Funding for Next-Gen Assets https://signalbloom.ai/news/ONC/beone-medicines-pivots-rd-slashes-brukinsa-funding-for-next-gen-assets $ONC #Earnings via @signalbloom.ai
August 26, 2026 at 10:18 AM
📰 #Finance

"Renewed collaboration builds on access provided to more than 300 patients with CLL to date and plans to support approximately 1,000 patients through 2028 SAN CARLOS, Calif. & SEATTLE — BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global…"
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
financialpost.com
August 18, 2026 at 11:30 AM
I was diagnosed with CLL (Chronic Lymphocytic Leukemia) in 2009. I've had chemo 5 times. Each time it knocked back the bad lymphocytes and they gradually came back. Now I'm on Brukinsa, which has my blood numbers in the normal range. Quality of life has mostly been excellent, Thank God for insurance
August 9, 2026 at 2:47 AM
📰 #Finance

"Total global revenues of $1.7 billion for the second quarter, an increase of 30% from the prior year BRUKINSA (zanubrutinib) global revenues of $1.2 billion for the second quarter, an increase of 31% from the prior year Diluted GAAP Earnings per American Depository Share (ADS) of…"
BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates
financialpost.com
August 5, 2026 at 11:26 AM
📢 Beigene is #hiring a Director, Hcp Marketing Promotions, Brukinsa!

🌎 United States

🔗 http://jbs.ink/ynCr7TIYXlPk

#jobalert #jobsearch #ecommercejobs #aws #marketing
July 13, 2026 at 5:17 PM
Jefferies upgrades #$ONC from Hold to Buy and raises price target to $380, implying 27% upside. Strong Brukinsa outlook and solid tumor pipeline drive bullish view. notreload.xyz/xy/analyst-u...
Jefferies Upgrades BeOne Medicines (ONC) to Buy, PT $380
Jefferies upgraded BeOne Medicines, citing strong Brukinsa growth, promising cancer drugs, and potential 27% stock upside.
notreload.xyz
July 13, 2026 at 9:41 AM
📢 Beigene is #hiring a Director, Hcp Marketing Promotions, Brukinsa!

🌎 Worldwide

🔗 http://jbs.ink/q1vesWNjbhQt

#jobalert #jobsearch #aviationjobs #remotejob #remotework #wfh #aws #marketing
July 9, 2026 at 5:01 PM
Brukinsa (zanubrutinib) | Relatório de avaliação de financiamento público disponível na Infomed
swki.me/7Ic2oqTL
#infarmed #medicamentos #financiamentopúblico #brukinsa #zanubrutinib
Brukinsa (zanubrutinib) | Relatório de avaliação de financiamento público disponível na Infomed
Infarmed
swki.me
May 6, 2025 at 11:45 AM
Brukinsa (Zanubrutinib) | Relatório de avaliação de financiamento público disponível na Infomed
➡ swki.me/XtjWzl9e

#infarmed #medicamentos #financiamentopúblico #zanubrutinib
Brukinsa (Zanubrutinib) | Relatório de avaliação de financiamento público disponível na Infomed
Infarmed
swki.me
April 30, 2025 at 11:15 AM
Brukinsa (Zanubrutinib) | Relatório de avaliação de financiamento público disponível na Infomed - Deferimento
➡ swki.me/mLWQDmcz
#infarmed #zanubrutinib #medicamentos #financiamentopúblico
Brukinsa (Zanubrutinib) | Relatório de avaliação de financiamento público disponível na Infomed - Deferimento
Infarmed
swki.me
April 29, 2025 at 5:35 PM